Create Medicines vs CRISPR Therapeutics
Create Medicines vs CRISPR Therapeutics, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Create Medicines is on 60/100 and CRISPR Therapeutics on 64/100.
Where each one leads
Create Medicines
Leads on none of the measures we hold for both companies.
CRISPR Therapeutics
- our overall score: 64/100 against 60/100
- funding raised: $547M against $122M
At a glance
| Measure | Create Medicines | CRISPR Therapeutics |
|---|---|---|
| What it is | Developing in vivo immunotherapies for autoimmune diseases and cancer. | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. |
| Category | Biotechnology, HealthTech, Pharmaceuticals | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | Not published | 2013 |
| Headquarters | Cambridge, USA | Zug, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Create Medicines | CRISPR Therapeutics |
|---|---|---|
| Total funding | $122M | $547M |
| Latest round | Series B | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Create Medicines | CRISPR Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 64/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 70/100 |
| Search visibility | Not published | 13/100 |
| Quality | Not published | 88/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (44/100) |
| Domain ratingLink authority, 0-100 | Not published | 67/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Create Medicines | CRISPR Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Create Medicines vs CRISPR Therapeutics: common questions
Which is better, Create Medicines or CRISPR Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.
How do Create Medicines and CRISPR Therapeutics compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 60/100), funding raised ($547M against $122M).
Read the full Create Medicines review and pricing or the CRISPR Therapeutics review and pricing. You can also browse other Create Medicines alternatives we track.